Trial intelligence / Profile preview

Mometasone furoate nasal spray for sleep disturbances and daytime somnolence in seasonal allergic rhinitis

2005-004464-24Phase 4Completed

Sponsor
Integrated Therapeutics Group
Start
Mar 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Mometasone furoate nasal spray with Placebo nasal spray (2 arms). Started Mar 2006; status: completed.

02

Drugs

mometasone
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on 2005-004464-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004464-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call